{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T18:59:01Z","timestamp":1770231541786,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia (FCT), Portugal","doi-asserted-by":"publisher","award":["Grant PTDC\/SAU- ONC\/115513\/2009_FCOMP-01-0124-FEDER-015949"],"award-info":[{"award-number":["Grant PTDC\/SAU- ONC\/115513\/2009_FCOMP-01-0124-FEDER-015949"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s11033-019-05178-8","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T18:03:05Z","timestamp":1573581785000},"page":"877-886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Replication of GWAS identifies RTEL1, CDKN2A\/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3087-0624","authenticated-orcid":false,"given":"Marta","family":"Viana-Pereira","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-447X","authenticated-orcid":false,"given":"Daniel Antunes","family":"Moreno","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0888-3325","authenticated-orcid":false,"given":"Paulo","family":"Linhares","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8692-7936","authenticated-orcid":false,"given":"J\u00falia","family":"Amorim","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Nabi\u00e7o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-4245","authenticated-orcid":false,"given":"Sandra","family":"Costa","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7527-8187","authenticated-orcid":false,"given":"Rui","family":"Vaz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-7940","authenticated-orcid":false,"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"12","key":"5178_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/bjc.2016.354","volume":"115","author":"SR Alcantara Llaguno","year":"2016","unstructured":"Alcantara Llaguno SR, Parada LF (2016) Cell of origin of glioma: biological and clinical implications. Br J Cancer 115(12):1445\u20131450. https:\/\/doi.org\/10.1038\/bjc.2016.354","journal-title":"Br J Cancer"},{"issue":"1","key":"5178_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","volume":"109","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109(1):93\u2013108. https:\/\/doi.org\/10.1007\/s00401-005-0991-y","journal-title":"Acta Neuropathol"},{"key":"5178_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8010015","author":"M Paolillo","year":"2018","unstructured":"Paolillo M, Boselli C, Schinelli S (2018) Glioblastoma under Siege: an overview of current therapeutic strategies. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci8010015","journal-title":"Brain Sci"},{"issue":"2","key":"5178_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrneurol.2015.242","volume":"12","author":"PY Wen","year":"2016","unstructured":"Wen PY, Reardon DA (2016) Neuro-oncology in 2015: progress in glioma diagnosis, classification and treatment. Nat Rev Neurol 12(2):69\u201370. https:\/\/doi.org\/10.1038\/nrneurol.2015.242","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"5178_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors. Acta Neuropathol 131(6):803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"issue":"2","key":"5178_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/ijc.30057","volume":"139","author":"R Batista","year":"2016","unstructured":"Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC et al (2016) The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism. Int J Cancer 139(2):414\u2013423. https:\/\/doi.org\/10.1002\/ijc.30057","journal-title":"Int J Cancer"},{"key":"5178_CR7","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H et al (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499\u20132508. https:\/\/doi.org\/10.1056\/NEJMoa1407279","journal-title":"N Engl J Med"},{"issue":"2","key":"5178_CR8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/nan.12432","volume":"44","author":"P Wesseling","year":"2018","unstructured":"Wesseling P, Capper D (2018) WHO 2016 classification of gliomas. Neuropathol Appl Neurobiol 44(2):139\u2013150. https:\/\/doi.org\/10.1111\/nan.12432","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"26","key":"5178_CR9","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372(26):2481\u20132498. https:\/\/doi.org\/10.1056\/NEJMoa1402121","journal-title":"N Engl J Med"},{"issue":"6","key":"5178_CR10","doi-asserted-by":"publisher","first-page":"e000144","DOI":"10.1136\/esmoopen-2016-000144","volume":"1","author":"DS Noroxe","year":"2016","unstructured":"Noroxe DS, Poulsen HS, Lassen U (2016) Hallmarks of glioblastoma: a systematic review. ESMO Open 1(6):e000144. https:\/\/doi.org\/10.1136\/esmoopen-2016-000144","journal-title":"ESMO Open"},{"key":"5178_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/978-1-60327-492-0_14","volume":"472","author":"H Ohgaki","year":"2009","unstructured":"Ohgaki H (2009) Epidemiology of brain tumors. Methods Mol Biol 472:323\u2013342. https:\/\/doi.org\/10.1007\/978-1-60327-492-0_14","journal-title":"Methods Mol Biol"},{"issue":"9","key":"5178_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ncpneuro0289","volume":"2","author":"JA Schwartzbaum","year":"2006","unstructured":"Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M (2006) Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol 2(9):494\u2013503. https:\/\/doi.org\/10.1038\/ncpneuro0289","journal-title":"Nat Clin Pract Neurol"},{"issue":"66","key":"5178_CR13","doi-asserted-by":"publisher","first-page":"110635","DOI":"10.18632\/oncotarget.22372","volume":"8","author":"N Deng","year":"2017","unstructured":"Deng N, Zhou H, Fan H, Yuan Y (2017) Single nucleotide polymorphisms and cancer susceptibility. Oncotarget 8(66):110635\u2013110649. https:\/\/doi.org\/10.18632\/oncotarget.22372","journal-title":"Oncotarget"},{"issue":"6","key":"5178_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/neuonc\/nou003","volume":"6","author":"M Adel Fahmideh","year":"2014","unstructured":"Adel Fahmideh M, Schwartzbaum J, Frumento P, Feychting M (2014) Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. Neuro Oncology 6(6):807\u2013814. https:\/\/doi.org\/10.1093\/neuonc\/nou003","journal-title":"Neuro Oncology"},{"issue":"1","key":"5178_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1158\/1055-9965.EPI-08-0632","volume":"18","author":"Y Liu","year":"2009","unstructured":"Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M et al (2009) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18(1):204\u2013214. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-0632","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"5178_CR16","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1158\/1055-9965.EPI-08-1078","volume":"18","author":"R McKean-Cowdin","year":"2009","unstructured":"McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P et al (2009) Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 18(4):1118\u20131126. https:\/\/doi.org\/10.1158\/1055-9965.EPI-08-1078","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"5178_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1750-3639.2008.00170.x","volume":"19","author":"I Zawlik","year":"2009","unstructured":"Zawlik I, Kita D, Vaccarella S, Mittelbronn M, Franceschi S, Ohgaki H (2009) Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas. Brain Pathol 19(2):188\u2013194. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00170.x","journal-title":"Brain Pathol"},{"issue":"9","key":"5178_CR18","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1158\/1078-0432.CCR-06-2606","volume":"13","author":"BM Costa","year":"2007","unstructured":"Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A et al (2007) Association between functional\u00a0EGF\u2009+\u200961 polymorphism and glioma risk. Clin Cancer Res 13(9):2621\u20132626. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-2606","journal-title":"Clin Cancer Res"},{"issue":"12","key":"5178_CR19","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1158\/1055-9965.EPI-11-0340","volume":"20","author":"BM Costa","year":"2011","unstructured":"Costa BM, Viana-Pereira M, Fernandes R, Costa S, Linhares P, Vaz R et al (2011) Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiol Biomarkers Prev 20(12):2610\u20132617. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0340","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5178_CR20","doi-asserted-by":"publisher","first-page":"e28609","DOI":"10.4161\/onci.28609","volume":"3","author":"JP Pandey","year":"2014","unstructured":"Pandey JP, Kaur N, Costa S, Amorim J, Nabico R, Linhares P et al (2014) Immunoglobulin genes implicated in glioma risk. Oncoimmunology 3:e28609. https:\/\/doi.org\/10.4161\/onci.28609","journal-title":"Oncoimmunology"},{"issue":"12","key":"5178_CR21","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00439-012-1212-0","volume":"131","author":"P Rajaraman","year":"2012","unstructured":"Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS et al (2012) Genome-wide association study of glioma and meta-analysis. Hum Genet 131(12):1877\u20131888. https:\/\/doi.org\/10.1007\/s00439-012-1212-0","journal-title":"Hum Genet"},{"issue":"8","key":"5178_CR22","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00439-012-1212-0","volume":"41","author":"S Shete","year":"2009","unstructured":"Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41(8):899\u2013904. https:\/\/doi.org\/10.1007\/s00439-012-1212-0","journal-title":"Nat Genet"},{"issue":"7 Suppl","key":"5178_CR23","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/cncr.23741","volume":"113","author":"ML Bondy","year":"2008","unstructured":"Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il\u2019yasova D et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113(7 Suppl):1953\u20131968. https:\/\/doi.org\/10.1002\/cncr.23741","journal-title":"Cancer"},{"issue":"6","key":"5178_CR24","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/WCO.0000000000000033","volume":"26","author":"B Melin","year":"2013","unstructured":"Melin B, Jenkins R (2013) Genetics in glioma- lessons learned from genome wide association studies. Curr Opin Neurol 26(6):688\u2013692. https:\/\/doi.org\/10.1097\/WCO.0000000000000033","journal-title":"Curr Opin Neurol"},{"key":"5178_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000464374","volume":"30","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Stetson L, Virk S, Barnholtz-Sloan JS (2018) Epidemiology of intracranial gliomas. Prog Neurol Surg 30:1\u201311. https:\/\/doi.org\/10.1159\/000464374","journal-title":"Prog Neurol Surg"},{"issue":"4","key":"5178_CR26","doi-asserted-by":"publisher","first-page":"e95139","DOI":"10.1371\/journal.pone.0095139","volume":"9","author":"X Chen","year":"2014","unstructured":"Chen X, Yang G, Zhang D, Zhang W, Zou H, Zhao H et al (2014) Association between the epidermal growth factor +61 G\/A polymorphism and glioma risk: a meta-analysis. PLoS ONE 9(4):e95139. https:\/\/doi.org\/10.1371\/journal.pone.0095139","journal-title":"PLoS ONE"},{"issue":"3","key":"5178_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11060-016-2066-4","volume":"127","author":"S Ghasimi","year":"2016","unstructured":"Ghasimi S, Wibom C, Dahlin AM, Br\u00e4nnstr\u00f6m T, Golovleva I, Andersson U et al (2016) Genetic risk variants in the CDKN2A\/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. J Neurooncol 127(3):483\u2013492. https:\/\/doi.org\/10.1007\/s11060-016-2066-4","journal-title":"J Neurooncol"},{"issue":"14","key":"5178_CR28","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/hmg\/ddr192","volume":"20","author":"M Sanson","year":"2011","unstructured":"Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y (2011) Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 20(14):2897\u20132904. https:\/\/doi.org\/10.1093\/hmg\/ddr192","journal-title":"Hum Mol Genet"},{"issue":"3","key":"5178_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1010428318766273","volume":"40","author":"P Linhares","year":"2018","unstructured":"Linhares P, Viana-Pereira M, Ferreira M, Amorim J, Nabicxo R, Pinto F et al (2018) Genetic variants of vascular endothelial growth factor predict risk and survival of gliomas. Tumor Biol 40(3):1\u201311. https:\/\/doi.org\/10.1177\/1010428318766273","journal-title":"Tumor Biol"},{"issue":"3","key":"5178_CR30","first-page":"3862","volume":"8","author":"T Cui","year":"2015","unstructured":"Cui T (2015) CCDC26 rs4295627 polymorphism and glioma risk: a meta-analysis. Int J Clin Exp Med 8(3):3862\u20133868","journal-title":"Int J Clin Exp Med"},{"issue":"23","key":"5178_CR31","doi-asserted-by":"publisher","first-page":"10175","DOI":"10.7314\/apjcp.2014.15.23.10175","volume":"15","author":"SL Du","year":"2014","unstructured":"Du SL, Geng TT, Feng T, Chen CP, Jin TB, Chen C (2014) The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies. Asian Pac J Cancer Prev 15(23):10175\u201310179. https:\/\/doi.org\/10.7314\/apjcp.2014.15.23.10175","journal-title":"Asian Pac J Cancer Prev"},{"issue":"24","key":"5178_CR32","doi-asserted-by":"publisher","first-page":"38693","DOI":"10.18632\/oncotarget.16309","volume":"8","author":"H Li","year":"2017","unstructured":"Li H, Xu Y, Mei H, Peng L, Li X, Tang J (2017) The TERT rs2736100 polymorphism increases cancer risk: a meta-analysis. Oncotarget 8(24):38693\u201338705. https:\/\/doi.org\/10.18632\/oncotarget.16309","journal-title":"Oncotarget"},{"issue":"7","key":"5178_CR33","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/ng.3004","volume":"46","author":"KM Walsh","year":"2014","unstructured":"Walsh KM, Codd V, Smirnov IV, Rice T, Decker PA, Hansen HM et al (2014) Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk. Nat Genet 46(7):731\u2013735. https:\/\/doi.org\/10.1038\/ng.3004","journal-title":"Nat Genet"},{"issue":"2","key":"5178_CR34","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1530\/JME-16-0195","volume":"58","author":"A Pestana","year":"2017","unstructured":"Pestana A, Vinagre J, Sobrinho-Sim\u00f5es M, Soares P (2017) TERT biology and function in cancer: beyond immortalisation. J Mol Endocrinol 58(2):R129\u2013R146. https:\/\/doi.org\/10.1530\/JME-16-0195","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"5178_CR35","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/ng.408","volume":"41","author":"M Wrensch","year":"2009","unstructured":"Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41(8):905\u2013908. https:\/\/doi.org\/10.1038\/ng.408","journal-title":"Nat Genet"},{"key":"5178_CR36","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/aje\/kwq075","volume":"171","author":"MJ Schoemaker","year":"2010","unstructured":"Schoemaker MJ, Robertson L, Wigertz A, Jones ME, Hosking FJ, Feychting M et al (2010) Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol 171:1165\u20131173. https:\/\/doi.org\/10.1093\/aje\/kwq075","journal-title":"Am J Epidemiol"},{"issue":"17","key":"5178_CR37","doi-asserted-by":"publisher","first-page":"7163","DOI":"10.7314\/apjcp.2014.15.17.7163","volume":"15","author":"Y Wu","year":"2014","unstructured":"Wu Y, Tong X, Tang LL, Zhou K, Zhong CH, Jiang S (2014) Associations between the rs6010620 polymorphism in RTEL1 and risk of glioma: a meta-analysis of 20,711 participants. Asian Pac J Cancer Prev 15(17):7163\u20137167. https:\/\/doi.org\/10.7314\/apjcp.2014.15.17.7163","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"5178_CR38","doi-asserted-by":"publisher","first-page":"5259","DOI":"10.1007\/s13277-014-1684-8","volume":"35","author":"W Zhao","year":"2014","unstructured":"Zhao W, Bian Y, Zhu W, Zou P, Tang G (2014) Regulator of telomere elongation helicase 1 (RTEL1) rs6010620 polymorphism contribute to increased risk of glioma. Tumour Biol 35(6):5259\u20135266. https:\/\/doi.org\/10.1007\/s13277-014-1684-8","journal-title":"Tumour Biol"},{"issue":"18","key":"5178_CR39","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1093\/nar\/gks542","volume":"40","author":"SG Coetzee","year":"2012","unstructured":"Coetzee SG, Rhie SK, Berman BP, Coetzee GA, Noushmehr H (2012) FunciSNP: an R\/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res 40(18):e139. https:\/\/doi.org\/10.1093\/nar\/gks542","journal-title":"Nucleic Acids Res"},{"key":"5178_CR40","first-page":"e1022","volume":"3","author":"T Hirano","year":"2016","unstructured":"Hirano T (2016) The role of the CCDC26 long noncoding RNA as a tumor suppressor. RNA Dis 3:e1022","journal-title":"RNA Dis"},{"issue":"11","key":"5178_CR41","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1093\/hmg\/ddt063","volume":"22","author":"V Enciso-Mora","year":"2013","unstructured":"Enciso-Mora V, Hosking FJ, Kinnersley B, Wang Y, Shete S, Zelenika D et al (2013) Deciphering the 8q24.21 associations for glioma. Hum Mol Genet 22(11):2293\u20132302","journal-title":"Hum Mol Genet"},{"issue":"1","key":"5178_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cancergencyto.2010.10.002","volume":"204","author":"RB Jenkins","year":"2011","unstructured":"Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y et al (2011) Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genet 204(1):13\u201318. https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.10.002","journal-title":"Cancer Genet"},{"issue":"1\u20132","key":"5178_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00335-015-9612-9","volume":"27","author":"X Qi","year":"2016","unstructured":"Qi X, Wan Y, Zhan Q, Yang S, Wang Y, Cai X (2016) Effect of CDKN2A\/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants. Mamm Genome 27(1\u20132):1\u20137. https:\/\/doi.org\/10.1007\/s00335-015-9612-9","journal-title":"Mamm Genome"},{"issue":"10","key":"5178_CR44","first-page":"17480","volume":"8","author":"H Lu","year":"2015","unstructured":"Lu H, Yang Y, Wang J, Liu Y, Huang M, Sun X et al (2015) The CDKN2A-CDKN2B rs4977756 polymorphism and glioma risk: a meta-analysis. Int J Clin Exp Med 8(10):17480\u201317488","journal-title":"Int J Clin Exp Med"},{"key":"5178_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1755-8794-4-63","volume":"4","author":"TH Yang","year":"2011","unstructured":"Yang TH, Kon M, Hung JH, Delisi C (2011) Combinations of newly confirmed glioma-associated loci link regions on chromosomes 1 and 9 to increased disease risk. BMC Med Genomics 4:63. https:\/\/doi.org\/10.1186\/1755-8794-4-63","journal-title":"BMC Med Genomics"},{"issue":"3","key":"5178_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/br.2016.580","volume":"4","author":"MA Nagai","year":"2016","unstructured":"Nagai MA (2016) Pleckstrin homology-like domain, family A, member 1 (PHLDA1) and cancer. Biomed Rep 4(3):275\u2013281. https:\/\/doi.org\/10.3892\/br.2016.580","journal-title":"Biomed Rep"},{"issue":"4","key":"5178_CR47","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1111\/ajco.12211","volume":"11","author":"X Gao","year":"2015","unstructured":"Gao X, Mi Y, Yan A, Sha B, Guo N, Hu Z et al (2015) The PHLDB1 rs498872 (11q23.3) polymorphism and glioma risk: a meta-analysis. Asia Pac J Clin Oncol 11(4):e13\u2013e21. https:\/\/doi.org\/10.1111\/ajco.12211","journal-title":"Asia Pac J Clin Oncol"},{"issue":"7218","key":"5178_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature07331","volume":"456","author":"J Novembre","year":"2008","unstructured":"Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, Indap A, King KS, Bergmann S, Nelson MR, Stephens M, Bustamante CD (2008) Genes mirror geography within Europe. Nature 456(7218):98\u2013101. https:\/\/doi.org\/10.1038\/nature07331","journal-title":"Nature"},{"key":"5178_CR49","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/jnci\/djh075","volume":"96","author":"S Wacholder","year":"2004","unstructured":"Wacholder S, Chanock S, Garcia-Closas M, El GL, Rothman N (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434\u2013442. https:\/\/doi.org\/10.1093\/jnci\/djh075","journal-title":"J Natl Cancer Inst"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-019-05178-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-019-05178-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:43:53Z","timestamp":1605055433000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-019-05178-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5178"],"URL":"https:\/\/doi.org\/10.1007\/s11033-019-05178-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"2 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional ethics committees of S. Jo\u00e3o and Braga Hospitals (Approval 29\/10\/2007).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable. This is a retrospective study where any information that allows participants identification is not disclosed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}